News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
139 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18648)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1124)
Day
1 (214)
2 (187)
3 (160)
4 (138)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (132)
12 (58)
14 (27)
15 (145)
16 (92)
17 (98)
18 (106)
19 (70)
21 (14)
22 (92)
23 (109)
24 (105)
25 (106)
26 (50)
28 (28)
29 (103)
30 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
4
5
7
8
9
10
11
12
14
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Press Releases
Health Canada authorizes Lunsumio® (mosunetuzumab) for the treatment of relapsed or refractory follicular lymphoma after two or more systemic therapies
June 8, 2026
·
5 min read
Press Releases
Corsair Pharma Announces Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference
June 8, 2026
·
3 min read
Press Releases
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
June 8, 2026
·
6 min read
Press Releases
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization
June 8, 2026
·
2 min read
Press Releases
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
June 8, 2026
·
7 min read
Press Releases
Xealth Appoints Travis Moore as Chief Revenue Officer
June 8, 2026
·
2 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
June 8, 2026
·
3 min read
Deals
J&J glows with $1B buyout of Firefly and its degrader platform tech
The acquisition gives Johnson & Johnson access to Firefly Bio’s next-gen platform designed to create degrader antibody conjugates that can crack the tricky KRAS cancer target.
June 8, 2026
·
1 min read
·
Gabrielle Masson
Obesity
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
Novo Nordisk and Eli Lilly presented data extolling the benefits of their relative weight loss therapies in obesity-linked indications, while analysts at BMO Capital Markets were “encouraged” by the strategy communicated by Novo management.
June 8, 2026
·
5 min read
·
Heather McKenzie
Previous
14 of 14
